Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1ALDESLEUKIN
(Synonym: Interleukin-2)
[1] Aldesleukin (Synonym: Interleukin-2 aldesleukin)[1] D00748 (Name: Interleukin-2)[3] IL2RA,
IL2RB,
IL2RG 💬
[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[4] 49, 65, 96, 97
2Anti-Human Interleukin-23 Monoclonal Antibody----[1] 271
3Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Huma----[2] 96, 97
4Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human----[2] 96, 97
5Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody----[2] 96, 97
6Human interleukin-2[1] Human interleukin-2---[1] 35
7INTERLEUKIN-2[1] Human interleukin-2---[8] 2, 35, 49, 55, 65, 96, 97, 162
8Interleukin-2 (aldesleukin).[2] Aldesleukin (Synonym: Interleukin-2 aldesleukin),
Human interleukin-2
[1] D00748 (Name: Interleukin-2)[3] IL2RA,
IL2RB,
IL2RG 💬
[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[2] 96, 97
9Low-dose Aldesleukin (Proleukin®)
(Synonym: Interleukin-2)
[1] Aldesleukin (Synonym: Interleukin-2 aldesleukin)[1] D00748 (Name: Interleukin-2)[3] IL2RA,
IL2RB,
IL2RG 💬
[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[1] 49
10Monthly autologous Treg cells infusions + 3 times per week Interleukin-2 injections[1] Human interleukin-2---[1] 2
11PEG-interleukin-2[1] Human interleukin-2---[1] 65
12Recombinant human interleukin-2[2] Aldesleukin (Synonym: Interleukin-2 aldesleukin),
Human interleukin-2
[1] D00748 (Name: Interleukin-2)[3] IL2RA,
IL2RB,
IL2RG 💬
[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[1] 35
13Recombinant human interleukin-2 (rhIL-2)[2] Aldesleukin (Synonym: Interleukin-2 aldesleukin),
Human interleukin-2
[1] D00748 (Name: Interleukin-2)[3] IL2RA,
IL2RB,
IL2RG 💬
[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[1] 35